News

Filter

Current filters:

ReproductiveResearch

1 to 9 of 22 results

Evestra signs research accord with Gedeon Richter

Evestra signs research accord with Gedeon Richter

09-01-2014

Privately-held US firm Evestra says it has signed a collaboration partnership agreement with Hungary’s…

EvestraGedeon RichterLicensingPharmaceuticalReproductiveResearch

Merck KGaA eighth EPP spin-off to focus on infertility treatment

Merck KGaA eighth EPP spin-off to focus on infertility treatment

02-12-2013

USA-based EMD Serono, one of German drug and chemical group Merck KGaA’s biotechnology subsidiaries,…

BiotechnologyEMD SeronoMerck KGaAMerck SeronoMergers & AcquisitionsReproductiveResearchTocopheRx

New chemo drug gentler on fertility, tougher on cancer

24-03-2013

A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine…

OncologyPharmaceuticalReproductiveResearch

US researchers point way to a reversible oral male contraceptive pill

19-08-2012

scientists in the right direction to making oral birth control for men a reality. Researchers at Dana-Farber…

JQ1Men's HealthPharmaceuticalReproductiveResearch

Pfizer's Lyrica positive in two post-marketing studies

23-07-2012

Top-line results for global drugs behemoth Pfizer's already marketed diabetic nerve pain and post-herpetic…

LyricaNeurologicalPfizerPharmaceuticalReproductiveResearch

BioSante Pill-Plus improves sexual desire, arousal

20-03-2012

US drug developer BioSante Pharmaceuticals (Nasdaq: BPAX) says that data from studies of the Pill-Plus…

BioSante PharmaceuticalsLicensingPantarhei BiosciencePharmaceuticalPill-PlusReproductiveResearchWomen's Health

Merck & Co debuts Nexplanon in USA; gets negative FDA response on Zoely and Saflutan

10-11-2011

Merck & Co (NYSE; MRK), the USA’s second largest drugmaker, says that its Nexplanon (etonogestrel…

DiabetesJanuviaMarkets & MarketingMerck & CoNexplanonOphthalmicsPharmaceuticalRegulationReproductiveResearchSaflutanZoely

Lilly’s Cialis meets endpoints in Ph III study in men with both erectile dysfunction and BPH

13-10-2011

US drug major Eli Lilly (NYSE: LLY) says that a pivotal Phase III study of its blockbuster erectile dysfunction…

CialisEli LillyPharmaceuticalReproductiveResearch

1 to 9 of 22 results

Back to top